Phase 1b dose expansion and translational analyses of olaparib in combination with the oral AKT inhibitor capivasertib in recurrent endometrial, triple negative breast, and ovarian, primary peritoneal, or fallopian tube cancer
Shannon N. Westin(The University of Texas MD Anderson Cancer Center), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Allison Creason(Oregon Health & Science University), Anca Chelariu-Raicu(Ludwig-Maximilians-Universität München), Robert L. Coleman(Texas Oncology), Christopher P. Vellano(The University of Texas MD Anderson Cancer Center), Jennifer K. Litton(The University of Texas MD Anderson Cancer Center), Ying Yuan(The University of Texas MD Anderson Cancer Center), Aurora Blucher(Oregon Health & Science University), Rashmi K. Murthy(The University of Texas MD Anderson Cancer Center), Pamela T. Soliman(The University of Texas MD Anderson Cancer Center), Marilyne Labrie(Université de Sherbrooke), Joseph R. Marszalek(The University of Texas MD Anderson Cancer Center), Ningping Feng(The University of Texas MD Anderson Cancer Center), Jinsong Liu(The University of Texas MD Anderson Cancer Center), Karen H. Lu(The University of Texas MD Anderson Cancer Center), Bryan Fellman(The University of Texas MD Anderson Cancer Center), Michael Frumovitz(The University of Texas MD Anderson Cancer Center), Charlotte C. Sun(The University of Texas MD Anderson Cancer Center), Tae‐Beom Kim(The University of Texas MD Anderson Cancer Center), Sanghoon Lee(The University of Texas MD Anderson Cancer Center), Yong Fang(Tongji Hospital), Xiaoyan Ma(The University of Texas MD Anderson Cancer Center), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Nashwa Kabil(AstraZeneca (Japan)), Tsun Hsuan Chen(The University of Texas MD Anderson Cancer Center), Larissa A. Meyer, Katheleen M. Schmeler(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center)
Cited by 11
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
|Cancer Cell|2017|2.1k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k